US Patent 10562980 Humanized antibodies
Patent 10562980 was granted and assigned to the scripps research institute on February, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 11 Dec, 2023
Golden AI
Edits made to:
Article (+136 characters)
Article
Patent abstract
The present disclosure provides humanized antibodies, including antibodies comprising an ultralong CDR3 and uses thereof.
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Hongyuan Helen Mao0
Omar A. Bazirgan0
Vaughn Smider0
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105629800
Date of Patent
February 18, 2020
0Patent Application Number
158012510
Date Filed
November 1, 2017
0Patent Primary Examiner
Edits on 1 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 10562980 Humanized antibodies
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10562980
Date of patent
February 18, 2020
Patent application number
15801251
Date Filed
November 1, 2017
Patent primary examiner
Find more entities like US Patent 10562980 Humanized antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
